Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1998 • 4,679 citations

Revisions in the International System for Staging Lung Cancer

1997 • 4,582 citations

Beta blockade during and after myocardial infarction: An overview of the randomized trials

1985 • 3,248 citations

Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

1999 • 1,607 citations

Partial-Volume Effect in PET Tumor Imaging

2007 • 1,403 citations

Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions

2001 • 1,095 citations

Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non–Small-Cell Lung Cancer

2003 • 668 citations

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

2004 • 632 citations

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.

2001 • 608 citations

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

2004 • 602 citations

Prognostic Importance of the Standardized Uptake Value on ¹⁸F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases

1999 • 442 citations

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

2001 • 409 citations

Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer Resection

2004 • 360 citations

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1998 • 335 citations

The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival

2005 • 308 citations

Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis

2001 • 282 citations

[¹⁸F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung Cancer

2005 • 281 citations

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

2004 • 274 citations

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

2002 • 267 citations

18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

2002 • 266 citations

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

2002 • 237 citations

Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

1994 • 234 citations

Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature

2005 • 208 citations

The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.

1993 • 203 citations

The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer

2007 • 201 citations

Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer

2005 • 182 citations

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

2003 • 163 citations

[18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer✩

2000 • 154 citations

T1 Lung Cancers: Sensitivity of Diagnosis with Fluorodeoxyglucose PET

2002 • 154 citations

Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer

2002 • 148 citations

Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis

2006 • 140 citations

FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features

2000 • 112 citations

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

2003 • 112 citations

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data

2001 • 94 citations

Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

2005 • 90 citations

Non-small cell lung cancer: clinical value of new biological predictors

1997 • 75 citations

Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.

2006 • 61 citations

The 1997 International Staging System for Non-Small Cell Lung Cancer

1999 • 60 citations

VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse.

2002 • 55 citations

Positron emission tomographic scanning in the diagnosis and staging of non–small cell lung cancer 2 cm in size or less

2005 • 48 citations

Molecular and biological factors in the prognosis of non-small cell lung cancer

1995 • 45 citations

Does the FDG Uptake of Primary Non-Small Cell Lung Cancer Predict Prognosis? A Work in Progress

1999 • 28 citations

In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.

2004 • 26 citations

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy

2004 • 25 citations

18F-FDG in cardiology and oncology: the bitter with the sweet.

2002 • 12 citations

[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].

1997 • 9 citations